ArticleCardiovascular and interventional radiology2025

MOTIV Bioresorbable Scaffold in Below-The-Knee Artery Disease: European Post-Market Pilot BTK Trial: 36-Month Results.

Michel J Bosiers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.